Eurofins Discoverx FGFR1 (V561M), active, 10 µg. (14-734)

Supplier:  Eurofins Discoverx 14734

N-terminal GST-tagged recombinant, human FGFR1 amino acids 456-765 containing the V561 mutation. The coordinates for recombinant human FGFR1 were described in Homann et al. (2001). Blencke et al. (2004) suggested mutations to a conserved threonine residue at the ATP binding site would result in inhibitor resistance. The amino acid valine 561 was mutated to a methionine in FGFR1 which corresponded to previously reported mutations found in Abl (T315) and EGFR (T766) which had been shown to confer resistance to selective inhibitors. Assay data for FGFR1 V561M had shown that this mutation had conferred resistance to PP58 (pyrido [2,3-d] pyrimidine tyrosine kinase inhibitor) compared to that of the wild type. For detailed product information, visit www.discoverx.com/proteins.

Catalog No. 50-199-9257